Literature DB >> 23523103

Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer.

Di Zhao1, Shao-Wu Zou, Ying Liu, Xin Zhou, Yan Mo, Ping Wang, Yan-Hui Xu, Bo Dong, Yue Xiong, Qun-Ying Lei, Kun-Liang Guan.   

Abstract

Tumor cells commonly have increased glucose uptake and lactate accumulation. Lactate is produced from pyruvate by lactate dehydrogenase A (LDH-A), which is frequently overexpressed in tumor cells and is important for cell growth. Elevated transcription by c-Myc or HIF1α may contribute to increased LDH-A in some cancer types. Here, we show that LDH-A is acetylated at lysine 5 (K5) and that this acetylation inhibits LDH-A activity. Furthermore, the K5-acetylated LDH-A is recognized by the HSC70 chaperone and delivered to lysosomes for degradation. Replacement of endogenous LDH-A with an acetylation mimetic mutant decreases cell proliferation and migration. Importantly, K5 acetylation of LDH-A is reduced in human pancreatic cancers. Our study reveals a mechanism of LDH-A upregulation in pancreatic cancers.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523103      PMCID: PMC3885615          DOI: 10.1016/j.ccr.2013.02.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  38 in total

1.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  LACTIC DEHYDROGENASE IN HUMAN NEOPLASTIC TISSUES.

Authors:  R D GOLDMAN; N O KAPLAN; T C HALL
Journal:  Cancer Res       Date:  1964-04       Impact factor: 12.701

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  Proteins containing peptide sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats.

Authors:  S S Wing; H L Chiang; A L Goldberg; J F Dice
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres.

Authors:  K Ekwall; T Olsson; B M Turner; G Cranston; R C Allshire
Journal:  Cell       Date:  1997-12-26       Impact factor: 41.582

6.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

Authors:  H Shim; C Dolde; B C Lewis; C S Wu; G Dang; R A Jungmann; R Dalla-Favera; C V Dang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

Review 7.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

8.  Activation of a selective pathway of lysosomal proteolysis in rat liver by prolonged starvation.

Authors:  A M Cuervo; E Knecht; S R Terlecky; J F Dice
Journal:  Am J Physiol       Date:  1995-11

9.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

10.  Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; G Bougioukas; V Didilis; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more
  120 in total

1.  Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.

Authors:  L Li; R Fang; B Liu; H Shi; Y Wang; W Zhang; X Zhang; L Ye
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

Review 2.  Hepatic glucose sensing and integrative pathways in the liver.

Authors:  Maaike H Oosterveer; Kristina Schoonjans
Journal:  Cell Mol Life Sci       Date:  2013-11-07       Impact factor: 9.261

Review 3.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

Review 4.  The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.

Authors:  Douglas E Biancur; Alec C Kimmelman
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-04-24       Impact factor: 10.680

5.  Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis.

Authors:  Jiansheng Xie; Chunyan Dai; Xun Hu
Journal:  J Biol Chem       Date:  2016-02-25       Impact factor: 5.157

Review 6.  Dysregulated glycolysis as an oncogenic event.

Authors:  Takumi Mikawa; Matilde E LLeonart; Akifumi Takaori-Kondo; Nobuya Inagaki; Masayuki Yokode; Hiroshi Kondoh
Journal:  Cell Mol Life Sci       Date:  2015-01-22       Impact factor: 9.261

Review 7.  Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.

Authors:  Yi Zhu; Jiaqi Liu; Joun Park; Priyamvada Rai; Rong G Zhai
Journal:  Pharmacol Ther       Date:  2019-04-08       Impact factor: 12.310

8.  Acetylation targets HSD17B4 for degradation via the CMA pathway in response to estrone.

Authors:  Ye Zhang; Ying-Ying Xu; Chuan-Bo Yao; Jin-Tao Li; Xiang-Ning Zhao; Hong-Bin Yang; Min Zhang; Miao Yin; Jing Chen; Qun-Ying Lei
Journal:  Autophagy       Date:  2017-02-22       Impact factor: 16.016

Review 9.  Metabolism and epigenetics of pancreatic cancer stem cells.

Authors:  M Perusina Lanfranca; J K Thompson; F Bednar; C Halbrook; C Lyssiotis; B Levi; T L Frankel
Journal:  Semin Cancer Biol       Date:  2018-09-28       Impact factor: 15.707

10.  A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity.

Authors:  Hui Jing; Jing Hu; Bin He; Yashira L Negrón Abril; Jack Stupinski; Keren Weiser; Marisa Carbonaro; Ying-Ling Chiang; Teresa Southard; Paraskevi Giannakakou; Robert S Weiss; Hening Lin
Journal:  Cancer Cell       Date:  2016-03-14       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.